Lv2
190 积分 2023-10-19 加入
Discovery of a Highly Selective and H435R-Sensitive Thyroid Hormone Receptor β Agonist
22天前
已完结
Design and Evaluation of Conformationally Locked Indole-Carboxylic Acids as Selective THRβ Agonists against MASH
27天前
已完结
Discovery of Highly Potent, Selective, and Liver-Targeted THR-β Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
1个月前
已完结
Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial
1个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
2个月前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
2个月前
已完结
Targeting galectin-driven regulatory circuits in cancer and fibrosis
2个月前
已完结
Hepatic LGALS4 Alleviates Diet‐Induced Steatosis by Promoting AMPK‐Dependent Fatty Acid Oxidation
2个月前
已完结
Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLD
3个月前
已完结
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
5个月前
已完结
皖公网安备34019202002308
